News
Investor's Business Daily on MSN2d
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli LillyNovo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.
Zacks Investment Research on MSN4d
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback